|
Landiolol Impurity 35
|
蘭地洛爾雜質(zhì)35
|
|
|
Landiolol Impurity 43
|
蘭地洛爾雜質(zhì)43
|
|
|
Lacosamide impurity f CRS (designated brand EP cat. No. y0001989)
|
拉科酰胺雜質(zhì)F CRS（指定品牌EP 貨號(hào)Y0001989）
|
|
|
Nalmefene impurity 14
|
納美芬雜質(zhì)14
|
|
|
Beclomethasone propionate EP peak discrimination control (assigned brand EDQM y0000469)
|
丙酸倍氯米松EP峰鑒別對(duì)照品（指定品牌EDQM Y0000469)
|
|
|
Moxifloxacin peak discrimination (bedqm cat. No. y0002081)
|
莫西沙星峰鑒別（BEDQM 貨號(hào)Y0002081）
|
|
|
Oxacillin sodium EP Impurity J
|
苯唑西林鈉EP雜質(zhì)J
|
|
|
Edaravone Impurity 2
|
依達(dá)拉奉雜質(zhì)2
|
674-82-8
|
|
Nalmefene impurity 9
|
納美芬雜質(zhì)9
|
|
|
Ataluren impurities5
|
阿塔魯倫雜質(zhì)5
|
|
|
Linaclotide capsule impurity 1
|
利那洛肽膠囊雜質(zhì)1
|
|
|
Entecavir (R,R,S)-Isomer Hydrate
|
恩替卡韋-(R,R,S)-異構(gòu)體-水合物（恩替卡韋雜質(zhì)72）
|
|
|
Lactulose impurity 5
|
乳果糖雜質(zhì)5
|
|
|
Theophylline Impurity 11
|
茶堿雜質(zhì)11
|
39726-70-0
|
|
Pegylated phosphatidylethanolamine
|
培化磷脂酰乙醇胺
|
147867-65-0
|
|
Oryzanol impurity 5
|
谷維素雜質(zhì)5
|
20972-07-0
|
|
Utapenem USP Impurity O
|
厄他培南USP雜質(zhì)O
|
866317-77-3
|
|
Dronedarone Impurity 24
|
決奈達(dá)隆雜質(zhì)24
|
|
|
Utapenem USP Impurity L
|
厄他培南USP雜質(zhì)L
|
|
|
Landiolol Impurity 42
|
蘭地洛爾雜質(zhì)42
|
|
|
Isoproterenol Impurity 31
|
異丙腎上腺素雜質(zhì)31
|
|
|
1-butane, N - (2-chloroethyl) - N-ethyl
|
1-?丁烷，N-?(2-?氯乙基）?-?N個(gè)-?乙基
|
|
|
Vigabatrin USP related impurity E (specify brand USB cat. No. 1712045)
|
氨己烯酸USP有關(guān)雜質(zhì)E（指定品牌USB 貨號(hào)1712045）
|
|
|
Chondroitin sulfate sodium CRS(Designated brand EP Y0000280)
|
硫酸軟骨素鈉CRS(指定品牌EP Y0000280)
|
|
|
Lansoprazole impurity II (specified brand: Chinese Academy cat. No: 510047)
|
蘭索拉唑雜質(zhì)Ⅱ(指定品牌：中檢院 貨號(hào)：510047）
|
|
|
Indatrol Impurity 3
|
茚達(dá)特羅雜質(zhì)3
|
|
|
Regardsone impurity 12
|
瑞加德松雜質(zhì)12
|
|
|
Ornidazole Impurity 24
|
奧硝唑雜質(zhì)24
|
|
|
Vancomycin EP Impurity H
|
萬古霉素EP雜質(zhì)H
|
|
|
Brivaracetam Impurity 63
|
布瓦西坦雜質(zhì)63
|
|
|
Vonorasone impurity 4
|
伏諾拉生雜質(zhì)4
|
|
|
Landiolol Impurity 36
|
蘭地洛爾雜質(zhì)36
|
|
|
Landiolol Impurity 44
|
蘭地洛爾雜質(zhì)44
|
|
|
Ritgevir impurity e CRS (designated brand EP cat. No. y0001949)
|
雷特格韋雜質(zhì)E CRS(指定品牌EP 貨號(hào)Y0001949）
|
|
|
Nalmefene impurity 15
|
納美芬雜質(zhì)15
|
|
|
Rosuvastatin calcium (designated brand USP cat. No. 1606015
|
瑞舒伐他汀鈣（指定品牌USP 貨號(hào)1606015
|
|
|
Escitalopram system suitability (assigned brand EDQM cat. No. y0001797)
|
艾司西酞普蘭系統(tǒng)適用性（指定品牌 EDQM 貨號(hào)Y0001797）
|
|
|
Mitiglinide impurity 1
|
米格列奈雜質(zhì)1
|
|
|
Ornidazole Impurity 26
|
奧硝唑雜質(zhì)26
|
|
|
Pranoprofen Impurity 38
|
普拉洛芬雜質(zhì)38
|
|
|
Landiolol Impurity 29
|
蘭地洛爾雜質(zhì)29
|
4432-25-1
|
|
Vitamin K1 Impurity 2
|
維生素K1雜質(zhì)2
|
|
|
Linaclotide capsule impurity 2
|
利那洛肽膠囊雜質(zhì)2
|
|
|
Entecavir Impurity 73
|
恩替卡韋雜質(zhì)73
|
|
|
Beclomethasone propionate EP system suitability control article (designated brand EDQM y0000352)
|
丙酸倍氯米松EP系統(tǒng)適用性對(duì)照品（指定品牌EDQM Y0000352)
|
|
|
Landiolol Impurity 28
|
蘭地洛爾雜質(zhì)28
|
69630-20-2
|
|
Epalrestat Impurity 25
|
依帕司他雜質(zhì)25
|
|
|
Moxifloxacin Impurity 92
|
莫西沙星雜質(zhì)92
|
557-66-4
|
|
Isoproterenol Impurity 32
|
異丙腎上腺素雜質(zhì)32
|
|
|
Dronedarone Impurity 26
|
決奈達(dá)隆雜質(zhì)26
|
|
|
Azithromycin for system suitability CRS (designated brand EP cat. No. y0000641)
|
阿奇霉素用于系統(tǒng)適用性CRS(指定品牌EP 貨號(hào)Y0000641）
|
|
|
Lead solution CRS (designated brand EP Y0001996)
|
鉛溶液CRS(指定品牌EP Y0001996)
|
|
|
Landiolol Impurity 10
|
蘭地洛爾雜質(zhì)10
|
|
|
Landiolol Impurity 39
|
蘭地洛爾雜質(zhì)39
|
|
|
Isoproterenol Impurity 29
|
異丙腎上腺素雜質(zhì)29
|
|
|
Lacosamide impurity f CRS (designated brand EP cat. No. Y0002065)
|
拉科酰胺雜質(zhì)D CRS（指定品牌EP 貨號(hào)Y0002065）
|
|
|
Cilostazol Impurity 22
|
西洛他唑雜質(zhì)22
|
|
|
Fingolimod system suitability mix (designated brand USP cat. No. 1270526
|
芬戈莫德系統(tǒng)適用性混合物（指定品牌 USP貨號(hào)1270526
|
|
|
Ketoconazole Impurity 28
|
酮康唑雜質(zhì)28
|
|
|
Ilutinib impurity 7
|
依魯替尼雜質(zhì)7
|
143900-44-1
|
|
Nalmefene impurity 6
|
納美芬雜質(zhì)6
|
|
|
Ornidazole Impurity 25
|
奧硝唑雜質(zhì)25
|
|
|
Morpholinonitrazole impurity 5
|
嗎啉硝唑雜質(zhì)5
|
2213449-45-5
|
|
Adrenaline Impurity 60
|
腎上腺素雜質(zhì)60
|
|
|
N - (2-chloroethyl) - n-propyl-1-butanamine
|
N-?(2-?氯乙基）?-?N個(gè)-?丙基-?1-?丁胺
|
|
|
Linaclotide capsule impurity 3
|
利那洛肽膠囊雜質(zhì)3
|
|
|
Xylometazoline impurity A(assigned brand EP x0101000)
|
賽洛唑啉雜質(zhì)A（指定品牌EP X0101000)
|
|
|
Beclomethasone dipropionate impurities F and n (designated brand EP cat. No. y0001073)
|
二丙酸倍氯米松雜質(zhì)F和N（指定品牌EP 貨號(hào)Y0001073）
|
|
|
Citalopram r-oxalate (designated brand USP cat. No. 1134142)
|
R-草酸西酞普蘭（指定品牌USP 貨號(hào)1134142）
|
|
|
Brexpiprazole Impurity 8
|
依匹哌唑雜質(zhì)8
|
|
|
Nalmefene impurity 1
|
納美芬雜質(zhì)1
|
|
|
Edaravone Impurity 7
|
依達(dá)拉奉雜質(zhì)7
|
|
|
Ketoconazole Impurity 29
|
酮康唑雜質(zhì)29
|
133345-21-8
|
|
Ilaprazole Impurity 35
|
艾普拉唑雜質(zhì)35
|
163593-69-9
|
|
Naltrexone Impurity 13
|
納曲酮雜質(zhì)13
|
1201-90-7
|
|
Bisoprolol impurity f control article (designated brand TLC cat. No. b-0920)
|
比索洛爾雜質(zhì)F對(duì)照品（指定品牌TLC 貨號(hào)B-0920）
|
|
|
Ataluren impurities4
|
阿塔魯倫雜質(zhì)4
|
|
|
Abiraterone system suitability mix (designated brand USP 1000829)
|
阿比特龍系統(tǒng)適用性混合物（指定品牌USP 1000829）
|
|
|
Landiolol Impurity 31
|
蘭地洛爾雜質(zhì)31
|
|
|
Theophylline Impurity 9
|
茶堿雜質(zhì)9
|
42772-85-0
|
|
Landiolol Impurity 33
|
蘭地洛爾雜質(zhì)33
|
2180628-04-8
|
|
Morpholinonitrazole impurity 6
|
嗎啉硝唑雜質(zhì)6
|
1782143-94-5
|
|
Landiolol Impurity 38
|
蘭地洛爾雜質(zhì)38
|
|
|
Landiolol Impurity 41
|
蘭地洛爾雜質(zhì)41
|
|
|
Isoproterenol Impurity 30
|
異丙腎上腺素雜質(zhì)30
|
|
|
Ceftriaxone sodium impurity a ((specify brand EP cat. No. c0692000)
|
頭孢曲松鈉雜質(zhì)A（(指定品牌EP 貨號(hào)C0692000）
|
|
|
Vigabatrin USP related impurity B (specify brand USB cat. No. 1712023)
|
氨己烯酸USP有關(guān)雜質(zhì)B（指定品牌USB 貨號(hào)1712023）
|
|
|
Adapalene control article (designated brand USP cat. No. 1011709
|
阿達(dá)帕林對(duì)照品（指定品牌USP 貨號(hào)1011709
|
|
|
Salicylic acid tablets standard (designated brand: Chinese Academy cat. No: 100103)
|
水楊酸片標(biāo)準(zhǔn)品(指定品牌：中檢院 貨號(hào)：100103）
|
|
|
Sofosbuvir Impurity 32
|
索非布韋雜質(zhì)32
|
1157884-58-6
|
|
Clopidogrel impurity A
|
氯吡格雷雜質(zhì)A(指定EP貨號(hào)Y0001335）
|
|
|
Itraconazole System Suitability Mixture
|
伊曲康唑系統(tǒng)適用性混合物（指定 USP貨號(hào)1354262）
|
|
|
Nalmefene impurity 7
|
納美芬雜質(zhì)7
|
|
|
Cinnarizine Impurity 65
|
西替利嗪雜質(zhì)65
|
2705552-48-1
|
|
Pramipexole Impurity 77
|
普拉克索雜質(zhì)77
|
87976-86-1
|
|
Dronedarone Impurity 23
|
決奈達(dá)隆雜質(zhì)23
|
|
|
Beclometasone Propionate EP Impurity C
|
丙酸倍氯米松EP雜質(zhì)C
|
|
|
Dronedarone Impurity 25
|
決奈達(dá)隆雜質(zhì)25
|
|
|
Edaravone Impurity 5
|
依達(dá)拉奉雜質(zhì)5
|
|
|
Brinzolamide impurity 3
|
布林佐胺雜質(zhì)3
|
308358-88-5
|